TI
EDIT icon

Tidal Investments’s Editas Medicine EDIT Stock Holding History

Tidal Investments’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,674
Closed -$87.8K – 1945
2025
Q1 		$87.8K Sell
75,674
-6,230
-8% -$9.16K ﹤0.01% 1735
2024
Q4 		$104K Sell
81,904
-4,095
-5% -$10.4K ﹤0.01% 1781
2024
Q3 		$293K Sell
85,999
-31,436
-27% -$137K ﹤0.01% 1609
2024
Q2 		$548K Buy
+117,435
New +$662K 0.01% 1250

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tidal Investments's EDIT Position: Q2 2025 in Review

Tidal Investments sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 75,674 shares — an estimated $87.8K sold.

Tidal Investments first reported a position in EDIT in Q2 2024 and held it in 4 quarters. The position peaked at $548K in Q2 2024. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Tidal Investments reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Tidal Investments sold 75,674 Editas Medicine shares in Q2 2025, an estimated $87.8K.
  • Tidal Investments first reported a position in Editas Medicine in Q2 2024 and held it in 4 quarters.
  • Tidal Investments's Editas Medicine position peaked at $548K in Q2 2024.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Tidal Investments's 13F filing for Q2 2025, filed 14 Aug 2025.